selective 2′-hydroxyl acylation analyzed by primer extension (sHape) chemistries exploit small electrophilic reagents that react with 2′-hydroxyl groups to interrogate rna structure at single-nucleotide resolution. Mutational profiling (Map) identifies modified residues by using reverse transcriptase to misread a sHape-modified nucleotide and then counting the resulting mutations by massively parallel sequencing. the sHape-Map approach measures the structure of large and transcriptome-wide systems as accurately as can be done for simple model rnas. this protocol describes the experimental steps, implemented over 3 d, that are required to perform sHape probing and to construct multiplexed sHape-Map libraries suitable for deep sequencing. automated processing of Map sequencing data is accomplished using two software packages. shapeMapper converts raw sequencing files into mutational profiles, creates sHape reactivity plots and provides useful troubleshooting information. superFold uses these data to model rna secondary structures, identify regions with well-defined structures and visualize probable and alternative helices, often in under 1 d. sHape-Map can be used to make nucleotide-resolution biophysical measurements of individual rna motifs, rare components of complex rna ensembles and entire transcriptomes.
IntroDuctIon
RNA has many fundamental biological roles, often by interacting with other RNAs, proteins and small molecules [1] [2] [3] . In these roles, RNA molecules must adopt specific secondary and tertiary structures, the details of which are often difficult or impossible to characterize from sequence alone. A wide variety of chemical probing approaches have been proven to be powerful tools for understanding the critical features of RNA structure at both small and large scales [4] [5] [6] . Of these, SHAPE has emerged as a particularly useful strategy to probe RNA structure. SHAPE uses small hydroxyl-selective electrophilic reagents to probe the reactivity of the RNA ribose 2′-OH group. SHAPE reactivities are insensitive to base identity, and they correlate with local nucleotide flexibility and dynamics [7] [8] [9] , because flexible residues sample a wide range of conformations, a subset of which enhances the reactivity of the 2′-hydroxyl 10 (Fig. 1a) .
SHAPE chemistry makes it possible to thoroughly examine the RNA structure because, with the exception of some posttranscriptionally modified RNAs, all RNA nucleotides carry a 2′-hydroxyl group. SHAPE reactions are self-inactivating through a competing hydrolysis reaction with water (Fig. 1b) , and thus they require no specific quench step. Because few compounds have a net reactivity as high as 55 M water, intrinsic SHAPE reactivities are largely insensitive to the presence of (additional) competing small molecules, ligands and proteins. SHAPE experiments work robustly when they are performed in complex environments, including those inside virus particles [11] [12] [13] and in living cells [14] [15] [16] [17] . By careful choice of SHAPE reagent (Fig. 1c) 15, 16, 18 and experimental design, nucleotide flexibilities can be compared under different experimental or environmental conditions including cell-free versus in-cell and as a function of ligand and protein binding. When used as constraints in RNA modeling algorithms, SHAPE reactivity data yield accurate secondary structure models for many classes of RNA [19] [20] [21] .
Development of SHAPE-MaP, ShapeMapper and SuperFold
SHAPE and other RNA structure-probing approaches have recently been combined with massively parallel sequencing to enable the study of larger and more complex RNA systems 6, [22] [23] [24] [25] [26] [27] . Most of these approaches, except SHAPE-MaP, have used similar adapter-ligation methods, and they suffer from common limitations arising from multistep library preparation protocols and low signal levels (see Alternative Methods below). To overcome these limitations, we developed SHAPE-MaP, a direct, rapid and robust strategy for RNA structure probing at multiple scales.
SHAPE-MaP and ShapeMapper.
In SHAPE-MaP, SHAPE adducts are detected by MaP, which exploits an ability of reverse transcriptase enzymes to incorporate noncomplementary nucleotides or to create deletions at the sites of SHAPE chemical adducts (Fig. 2) 28 . The ability of reverse transcriptase to occasionally extend through chemical lesions in RNA has been noted previously 29, 30 . Because of the optimized primer extension conditions used in the MaP approach, at least 50% of the chemical adducts are detected 28 . The cDNAs generated are subjected to massively parallel sequencing, and mutations are counted to create SHAPE reactivity profiles using ShapeMapper (Fig. 2) .
Because MaP sequencing data are digital and because both chemical modification and (no-reagent) non-modification are recorded for every nucleotide, analysis yields mutation frequencies. This enables two important advances over prior analog and other sequencing approaches. First, the signal requires no heuristic rescaling before background removal. Second, the s.e.m. (a measurement of variability) associated with each SHAPE reactivity can be computed 28 . These s.e.m. are conveniently viewed as error bars on reactivity profile plots, which are automatically produced by ShapeMapper.
Mismatches comprise ~60% of the sequence mutation signal detected by SHAPE-MaP; deletions make up the other 40%. Many deletions cannot be located unambiguously with single-nucleotide accuracy, especially in regions of repeated or homopolymeric sequence. For typical RNAs, ~55% of detected deletions (22% of total mutations) align ambiguously. ShapeMapper automatically detects ambiguously aligned deletions ( Supplementary Fig. 1 ) and excludes them from analysis to yield better agreement between SHAPE-MaP and previously validated SHAPE experiments (Supplementary Fig. 2 ).
All current information supports the view that the MaP approach recovers chemical probing data equally well as prior gold-standard capillary electrophoresis methods. The MaP approach was intensively validated using a test set of RNAs ranging in size from 75 to 3,000 nt (ref. 28) . SHAPE-MaP has been recently used to analyze the entire HIV-1 and hepatitis C virus RNA genomes (~9,200 and 9,650 nt) 28, 31, 32 . The new models for these two RNAs recapitulate nearly all previously known and accepted functional motifs, and, moreover, contain multiple new structural and functional elements including experimentally validated pseudoknots 28 and other structures 31, 32 .
SuperFold algorithm. We recently developed a folding pipeline for modeling large RNAs 28 . This pipeline, now called SuperFold, is fully automated (Fig. 3) . SuperFold takes a windowing approach to folding of large RNAs. For long RNAs, practical window size choices are roughly 1,200 nt for a partition function calculation and 3,000 nt for a minimum free-energy calculation. Dividing the folding of a large RNA into smaller segments allows modern multicore workstations to model RNA structures in a modest amount of time. SuperFold runs in three main stages ( Table 1) : partition function calculation, minimum free-energy calculation and structural analysis (Fig. 3) . The partition function and minimum free-energy structure calculation are implemented using RNAstructure 33 , which enables direct incorporation of SHAPE reactivity information [19] [20] [21] .
Two assumptions are made to model RNA folding in windows. The first is that RNA structure is predominately local in nature.
A maximum pairing distance of 600 nt is currently implemented in RNAstructure. It is a practical, but imperfect, assumption that pairing does not occur outside this number of nucleotides 19, 21 . A consequence of this implementation is that improperly choosing the 'ends' of an RNA will introduce (potentially) cascading effects on nucleotide pairing. To mitigate this effect, predicted structures 300 nt from the 5′ and 3′ ends of a given window are removed. The second assumption is that the most stable structure will predominate despite potentially poorly chosen 5′ and 3′ ends. SuperFold combines predicted pairs from overlapping windows, and it requires that base pairs occur in more than half of potential cases to be retained in a minimum free-energy secondary structure model. The partition function computed over a given RNA can be used to distinguish regions of RNA that form well-defined structures from those that are likely to exist as an ensemble of structures 34 . SuperFold calculates the partition function in windows of 1,200 nt. Interactions within 300 nt of the window 5′ and 3′ ends are removed. Pairing probabilities are then averaged across each window in which a given base pair is able to occur. Additional partition function calculations are performed using the true 5′ and 3′ ends to reduce de-weighting of the partition function at the ends of RNA.
The partition function can also be used to identify helices that are most likely to be modeled correctly. Nucleotides with predicted pairing probabilities above 0.99 appear to be correct >90% of the time 35 . This observation is used to constrain the minimum free-energy structure prediction using RNAstructure Fold in 3,000-nt sliding windows. Highly probable pairs, based on the partition function within a folding window, are constrained to be base-paired. Nucleotides split by an overlapping window are forced to be single-stranded. The combination of these two constraints mitigates the effects of inadvertently poorly chosen ends.
Identifying well-determined RNA structures. From the partition function of base pairing, a SHAPE data-informed Shannon entropy 36 can be calculated. Analysis of the Shannon entropy of base pairing can be used to quantify the diversity of RNA (c) Overview of the three most useful SHAPE reagents. 1M7 is the workhorse SHAPE reagent; its reactivity with RNA measures local nucleotide flexibility 7, 8, 18 . 1M6 and NMIA are selective for nucleobases that have one face available for stacking and that achieve a reaction-competent conformation on a slow time scale, respectively. Together, 1M6 and NMIA can be used to detect noncanonical and tertiary interactions in RNA 53 and to increase the accuracy of secondary structure modeling 21 .
conformations within a given region 28, 35 . Low SHAPE reactivity across a region of RNA is indicative of stable base pairing.
Regions that have both low SHAPE reactivities and low Shannon entropy are likely to exist in a single structural state, and they have been found to be highly correlated with known functional RNA structures in both the HIV-1 and hepatitis C virus RNA genomes 28, 31 . Regions are calculated as the median over 55-nt windows of Shannon entropy and SHAPE reactivity. Because these regions of low Shannon entropy and SHAPE reactivity are calculated over (large) windows, base pairs may fall outside of strict boundaries. In SuperFold, these regions are discovered and then expanded to include nearby minimum free-energy model helices that cross low SHAPE and low Shannon entropy boundaries to contain complete helical elements and to account for imprecise boundaries of well-determined regions.
Pseudoknots.
The de novo discovery of RNA pseudoknots remains challenging. Several new pseudoknots were discovered in the HIV-1 RNA genome using a process that was not fully automated 28 . We have obtained good results using the ShapeKnots algorithm 20 with 700-nt windows in 50-nt steps. Pseudoknots that appear in a majority of windows are set aside for further analysis by an expert user for plausibility. Additional experimental validation or evolutionary support should then be sought because, in practice, false positive predictions are obtained with arbitrarily chosen 5′ and 3′ window boundaries. Once a pseudoknot has been located, the pseudoknot can be readily flagged in SuperFold.
Overview of the procedure
Here we provide a detailed protocol for SHAPE-MaP and for subsequent data analysis using ShapeMapper and SuperFold 28 . For simplicity, the PROCEDURE focuses on a straightforward folding approach for interrogating native-like or deproteinized RNA with 1-methyl-7-nitroisatoic anhydride (1M7). Adapting the protocol for other RNAs, for in-cell conditions, and for other SHAPE reagents is discussed in Experimental design. The key stages of the PROCEDURE are as follows:
SHAPE modification of RNA. SHAPE electrophiles are added to the folded RNA (or virus or cell) and then incubated until the reagent has either reacted with RNA or degraded via hydrolysis with water (five hydrolysis half-lives, Fig. 1b,c) . Two control reactions are performed in parallel: a no-reagent control and a denaturing control. In the no-reagent control reaction, folded RNA is incubated with solvent only (typically DMSO for SHAPE reagents); this important control measures the intrinsic background mutation rate of reverse transcriptase under MaP conditions, and it also detects certain naturally occurring RNA modification events. In the denaturing control reaction, RNA is suspended in a denaturing buffer containing formamide and it is incubated at 95 °C before modification with SHAPE reagent. Nucleotides are modified relatively evenly in this step, and the resulting site-specific mutation rates account for subtle sequence-and structure-specific biases in detection of adductinduced mutations. Thus, a complete SHAPE-MaP experiment consists of three reactions: plus-reagent (+), minus-reagent (−) and denaturing control (DC). The tagmentation (Nextera) library preparation used in this protocol requires that only double-stranded DNA (dsDNA), which are derived from the RNA that is being structurally interrogated, be present in the sample. It is thus crucial that genomic DNA and template DNA from cellular and in vitro-transcribed samples, respectively, be completely removed before reverse transcription and subsequent library preparation steps. Cellular or viral RNAs that were obtained by gentle extraction to maintain secondary structure should be DNase-treated following SHAPE modification, before reverse transcription. For in vitro-transcribed RNAs, The resulting cDNA is processed through one of three workflows (Fig. 4) and subjected to massively parallel sequencing. (d-f) ShapeMapper then aligns sequenced reads back to the target sequence (d), calculates mutation rates (e) and generates SHAPE reactivity profiles (f). SHAPE reactivities can be used to model secondary structures, visualize competing and alternative structures and quantify any process that modulates local nucleotide RNA dynamics.
a DNase treatment is conveniently performed immediately after in vitro transcription.
MaP by reverse transcription. After SHAPE modification of RNA, reverse transcriptase is used to create a MaP. This step encodes the positions and relative frequencies of SHAPE adducts as mutations in the cDNA sequence. Mutational profiling is efficient, with roughly 50% of SHAPE adducts detected as mutations in the cDNA 28 . The reverse transcription reaction conditions are the same for any RNA, but the researcher has two options for DNA primer type. RNAs that are small enough to be sequenced end-toend in a single massively parallel sequencing read (read lengths up to 600 nt are currently possible) can be subjected to reverse transcription with standard sequence-specific DNA primers. Specific primers can also be used to probe a specific subregion of a large RNA (Fig. 4 , small RNA workflow and amplicon workflow). The use of gene-or region-specific primers also makes it possible to analyze a specific, rare RNA in a complex mixture of RNAs. This is especially useful for in-cell studies. For the analysis of large RNAs, the constituents of entire transcriptomes or of multicomponent ribonucleoprotein or long noncoding RNA assemblies, random primers facilitate even coverage of complex RNA states in a single experiment (Fig. 4 , randomer workflow). After mutational profiling with appropriate primers, one of these three workflows (Fig. 4) is then used for library construction.
Library construction and sequencing. The small RNA workflow is ideally suited for short RNAs or subregions of large RNAs that are sufficiently short to be completely sequenced by a single unpaired sequencing read or by two mated paired-end sequencing reads. Libraries prepared with this workflow reflect the strandedness of the original RNA. After reverse transcription with sequence-specific primers, purified cDNA is 'tagged' with incomplete platform-specific adapters in a limited-cycle PCR reaction. The resulting dsDNA product is purified and further amplified in a second PCR reaction that completes the platformspecific adapters and adds sequences necessary for multiplexing (see Reagent Setup). After purification, sequencing libraries are of uniform size, and each DNA molecule contains the entire sequence of interest (Fig. 5a) . The amplicon workflow is well suited for large, low-abundance RNAs or for subregions of large RNAs that cannot be sequenced end-to-end by a single sequencing read. After reverse transcription, purified cDNA is amplified via PCR with sequence-specific primers. The resulting dsDNA is then enzymatically fragmented and tagged with platform-specific adapters and multiplexing indices. Sequencing libraries constructed in this way are of variable size; each molecule contains a fragment of the original amplicon (Fig. 5b) . Information regarding the strand of origin is lost with this method. Typically, when the amplicon workflow is used to construct a sequencing library, reverse transcription is primed with sequence-specific primers. However, if the researcher wishes to generate a sequencing library for a specific region of RNA that was initially converted to cDNA using random primers, the amplicon workflow allows for targeted 're-construction' of libraries.
The randomer workflow can be used to construct sequencing libraries when the RNA of interest is large (greater than ~500 nt) and reasonably pure; for example, in the case of a viral RNA genome. The randomer workflow also is appropriate for the analysis of very complex systems including complete RNA transcriptomes. Researchers who wish to examine RNAs for which sequence directionality is unknown should use alternate, strand information-preserving methods (not described in this protocol). After reverse transcription with appropriate random primers, purified cDNA is converted to dsDNA and then enzymatically fragmented and tagged with platform-specific adapters and multiplexing indices. The resulting sequencing library is of variable size, and each molecule corresponds to a fragment of the original RNA (Fig. 5c) .
After construction of high-quality SHAPE-MaP libraries, the libraries are subjected to sequencing with a massively parallel sequencing instrument. This protocol describes the preparation of libraries that are compatible with Illumina sequencing instruments. However, the MaP approach is fully compatible with any platform with a high per-nucleotide calling accuracy. To accurately recover nucleotide-resolution structural information, SHAPE-MaP requires high read depths across all regions of the RNA of interest.
For a given RNA, SHAPE-MaP involves the generation of sequencing data for RNA treated under three distinct experimental conditions: plus-reagent, minus-reagent and denaturing control. For input into ShapeMapper, these samples can either be sequenced separately or sequenced together and deconvoluted using multiplexed barcodes (such as Illumina TruSeq). Sequencing reads should be output as FASTQ files; this format is widely available with modern sequencing platforms.
Hit level and read depth requirements. As discussed in the initial SHAPE-MaP publication and by other investigators 24, 37 , the physical accuracy of an RNA structure-probing experiment is tightly coupled to both the observed signal above background and the sequencing read depth; these issues are often overlooked for approaches that link chemical probing and massively parallel sequencing. To consistently and accurately model RNA structures, we recommend a 'hit level' (total background-corrected signal per transcript nucleotide) of ~5 or greater, which corresponds to a per-nucleotide read depth of ~1,000-2,000 given current SHAPE adduct-induced mutation rates 28 . This is substantially Step 2 PCR (25 cycles higher than the depths required to assess RNA expression levels, to perform ribosome profiling or to enable genome assembly. In a SHAPE-MaP experiment, structure probing information is obtained for most nucleotides in a sequencing read. Given that sequencing reads of 100-600 or more nucleotides are now routine, these read-depth requirements are readily attainable using current technology. Multiple RNAs, each thousands of nucleotides long, can be sequenced at sufficient depth for accurate SHAPE-MaP structure modeling in a single run on a laboratoryscale instrument.
Generation of SHAPE profiles with ShapeMapper.
ShapeMapper is designed to run to completion with no user intervention following the setup step. A simple user-edited configuration file informs ShapeMapper which RNA sequences are present in each file and which sequences correspond to the three experimental conditions. The configuration files also define several global run parameters (Box 1). ShapeMapper uses a single Python script that is executed by the user to begin analysis, and it then runs each analysis stage in series. Several analysis stages rely on third-party programs (see Supplementary Method 1 and Table 2 ); the most important of which is the sequence alignment software Bowtie2 (ref. 38) , although any algorithm that supports gapped alignment could be substituted.
For short RNAs with high-quality SHAPE data (small standard errors), SHAPE reactivities can be fed directly into RNAstructure 33 as soft constraints [19] [20] [21] for structure modeling. For larger RNAs, the windowed folding strategy implemented in SuperFold is required.
Applications of SHAPE-MaP
MaP allows RNAs of virtually any size to be analyzed in a single experiment, facilitates rapid multiplexed library preparation and permits fully automated data analysis. The effects of sequence polymorphism and coexisting riboSNitches 28 can be evaluated and compared from single experiments, provided that the region under interrogation is completely sequenced in each read. The MaP experiment includes a DNA amplification step; therefore, RNAs that are present in scarce amounts or in complex mixtures can be examined. The MaP approach even enables probing of synthetic genetic polymers (XNAs), which are nucleic acid-like molecules with backbone chemistries not found in nature 39 . In sum, any RNA that can be amplified by RT-PCR should be amenable to single-nucleotide-resolution SHAPE-MaP analysis.
SHAPE-MaP reactivity information can be used in numerous informative ways. For large-scale RNA structure analysis, three applications are especially useful. First, SHAPE reactivities, coupled with an estimate of how often regions form unique versus competing folds, can be used to identify regions that are likely to be structured 28, 31 . These highly structured regions appear to correlate strongly with functional motifs. Second, SHAPE reactivity data can be incorporated as a pseudo-free-energy change term for RNA secondary structure modeling. In extensive validation experiments, this approach recovers 90% or more of accepted base pairs in well-characterized RNAs 21, 28 . Third, SHAPE reactivity data are ideal for visualizing changes in RNA structure as a function of diverse biological processes such as ligand binding 40, 41 , RNA folding and assembly [42] [43] [44] , and interaction with proteins 11, 12, 44 , and for evaluating the complex effects of the cellular environment [15] [16] [17] . SHAPE-MaP experiments efficiently generate RNA chemical probing data across many thousands of nucleotides.
Alternative methods
There has recently been intense interest in linking RNA structure probing with readout by massively parallel sequencing [22] [23] [24] [25] [26] [27] , and the reagents used for structure probing have been extensively reviewed 4, 6 . The MaP strategy is unique because the sites of chemical modification are recorded within sequence reads rather than at their termini. In other strategies, reverse transcription is blocked by the base modification, and thus the terminus of the sequenced fragment corresponds to a site of chemical modification in the targeted RNA. These adduct-terminated fragments are then prepared for massively parallel sequencing using approaches based on construction of conventional RNA-seq libraries. These methods all measure RNA modifications using single-stranded adapter ligation, which is strongly influenced both by local sequence and structural effects and by many postligation library preparation steps 45 . In our laboratory, we found that two distinct approaches using single-stranded adapter ligation failed to maintain the quantitative relationship between SHAPE probing and the underlying RNA structure 46 . In addition, many early methods used chemical or enzyme reagents that react with and report on only a subset of the four major RNA nucleotides. These data lead to notable blank spots in RNA structural information, and it is not known how to use such data to model large RNA structures with high accuracy. In the MaP strategy, the reverse transcriptase enzyme reads through the sites of chemical adducts in RNA: it does not matter where the cDNA begins or ends. MaP experiments therefore appear to be largely impervious to the substantial sequence-and structure-based biases introduced during construction of the libraries required for massively parallel sequencing. The MaP approach is also insensitive to single-strand breaks and background degradation, and it does not exhibit signal decay ##Specify which files correspond to the three experimental conditions ##(SHAPE-modified, untreated, and denatured control) and name each ##reactivity profile to be output.
[profiles] name = TPP riboswitch target = TPP_riboswitch plus_reagent = 1 minus_reagent = 2 denat_control = 4 name = Small subunit ribosome target = 16S plus_reagent = 3, more_16S minus_reagent = 2 denat_control = 7 or drop-off with long cDNA products 28 ; these effects result in substantial noise for alternative sequencing-based strategies for detecting chemical modification of RNA.
The ability to recover RNA structure information accurately has the direct consequence that SHAPE-MaP reactivities make possible RNA secondary structure modeling using well-established and well-validated parameters 20, 21 . On the basis of the analysis of a test set of small and large RNAs, SHAPE-directed secondary structure modeling recovers accepted base pairs with an overall sensitivity of 92% and a positive predictive value of 86% (ref. 28) . Structure probing approaches based on single-stranded adapter ligation have met with limited success in data-driven structure modeling. Most reports have not examined structure modeling accuracy 22, 23, 25, 26, 37 , have reported low accuracies 24, 27, 37 or have focused on short RNAs 47 . 59 RUN/output/folds/*.eps: postscript image files for the lowest predicted free energy structure colored by SHAPE reactivity, for each RNA specified in configuration section ' [folds]' . RUN/output/folds/*.xrna: XRNA files for each lowest predicted free energy structure, which can be manually edited if desired
The initialization stage is directly executed by the user; all subsequent stages are launched automatically from the ShapeMapper.py script. 'RUN' indicates the path to the folder from which ShapeMapper was executed, which should contain FASTA reference sequences, raw sequencing reads and a configuration file. 'conf' indicates configuration file parameters. '*' is a wild-card character indicating multiple names.
Advantages and limitations
MaP is a robust biochemical strategy for the quantification of the extent of chemical adducts at individual nucleotides in nucleic acids 28, 31, 39, 48 . SHAPE-MaP equips any laboratory able to sequence DNA with the ability to probe nucleic acid structure at large scales and with nucleotide-resolution accuracy.
Extensive validation experiments indicate that MaP enables nucleic acid probing experiments, read out by massively parallel sequencing, to reveal the underlying RNA structural information at the same high level of quantitative accuracy as prior highly labor-intensive approaches. There are two fundamental physical requirements for successful SHAPE-MaP RNA structure interrogation. First, the RNA must be long enough to allow primer binding for reverse transcription. RNAs smaller than ~150 nt are inefficiently recovered by the randomer workflow, and native (not in vitro transcribed) RNAs smaller than ~40 nt are difficult to study even using the small RNA workflow. Second, there must be a sufficient number of RNA molecules in the sample to accurately measure chemical adduct-induced mutation rates. Exceptionally rare transcripts or structures may simply not produce sufficient signal to be accurately distinguished from background noise.
ShapeMapper enables the rapid, automated analysis of data from MaP experiments using current-generation massively parallel sequencing instruments. A typical MiSeq experiment can be analyzed in less than an hour. ShapeMapper is optimized for analyzing lab-scale MaP experiments (total FASTQ file size under ~40 Gb). Larger data sets should be run in batches.
The RNA structure modeling rules implemented in SuperFold have been benchmarked against experimentally validated large RNAs with well-defined secondary structures, primarily the structures of rRNAs 28 . The validations that we have performed have been the most ambitious undertaken by any group to date. Although rRNAs make up a substantial fraction of the total mass of RNA in a cell, these RNAs may have overall structural features that are distinct compared with the diverse mRNAs, small RNAs, noncoding RNAs and long noncoding RNAs that are also present in cells. In addition, there are many functionally essential pairing interactions that are known to occur over thousands of nucleotides, outside the limits of current practical computational analysis 21, 49 .
Experimental design Controls.
Researchers who are new to RNA structure probing experiments may wish to include a positive control RNA in their experiments. We suggest using one of many well-structured RNAs that fold robustly and have been previously examined with SHAPE-MaP 28 . This control can be spiked into samples, as long as it does not interact with the experimental RNA of interest.
RNAs and RNA folding. SHAPE-MaP may be applied to RNAs of any length or complexity; however, as SHAPE inherently probes the ensemble of RNA molecules present in the system of interest, conditions should be selected to ensure that the RNA sample is folded in a biologically relevant and informative state before probing. Depending on the experimental aims, researchers may choose to probe RNA transcripts synthesized in vitro, native transcripts gently isolated from cells or virions, entire transcriptomes in living cells, or a combination of these. Small, well-structured RNAs (for example, riboswitches and ribozymes) are generally amenable to in vitro transcription and refolding, whereas probing of large RNAs such as ribosomes should be performed using RNA extracted from cells under native-like conditions to preserve secondary and tertiary structure. Conditions for refolding many (but not all) in vitro-transcribed RNAs 7,50,51 and for extraction and purification of large, complex RNAs from virions and cells under nondenaturing conditions have been described [11] [12] [13] 19, 52 and will not be extensively detailed here. Generally, when extracting RNA from cells or virions, the use of denaturants, divalent ion chelators and elevated temperature should be avoided. Direct interrogation of RNA structure inside cells by SHAPE works well [14] [15] [16] [17] . The protocol described here emphasizes simple folding procedures for interrogating relatively simple, in vitro-transcribed RNAs, but any procedure that folds RNA into an informative state can be used, provided that the pH is in the range of 7.4-8.3.
SHAPE probing reagents.
In this protocol, we emphasize the use of 1M7 (ref. 18) , which is well validated for RNA structure analysis and modeling. Essentially identical approaches can be used with reagents 1-methyl-6-nitroisatoic anhydride and N-methyl-isatoic anhydride (1M6 and NMIA, respectively; Fig. 1c) , and other reagents. Reactions with 1M6 are selective for nucleotides in which one face of the nucleobase is available for stacking. NMIA is used to identify nucleotides that are undergoing relatively slow conformational changes. These reagentspecific reactivities can be used both to identify residues that participate in noncanonical interactions and to improve RNA secondary structure modeling 21, 53 . In addition, the MaP strategy can be used to follow time-resolved RNA processes, in 1-s snapshots, using the benzoyl cyanide (BzCN) reagent 42, 54, 55 . The modest solubility and rapid hydrolysis of these reagents make overmodification of RNA samples virtually impossible.
In-cell analysis. No major changes are required to execute this protocol after in-cell SHAPE probing and extraction of total cellular RNA by standard methods. Although Spitale et al. 14 suggested that well-validated SHAPE reagents (Fig. 1) are not suitable for in-cell studies, our extensive experience indicates that these SHAPE reagents work well in bacterial cells [15] [16] [17] and in multiple mammalian cell lines, including human lymphoblastoid, There are important experimental and biophysical advantages in using the fast-reacting and extensively validated 1M7 SHAPE reagent for in-cell RNA structure probing. First, 1M7 reacts over a period of roughly 2 min before being consumed by hydrolysis 15, 18 . This time frame nicely balances experimental ease of use with a biologically relevant time scale. Second, because 1M7 autoinactivates within a few minutes, it is not necessary to add potentially harsh quenching agents. This feature allows intact RNA and RNA-protein complexes to be recovered from cells 17 . Third, 1M7 is relatively insensitive to trivial and nonbiological features of a solution such as divalent ion concentrations 18 . This means that, using 1M7, SHAPE reactivities for in-cell versus extracted or cell-free RNAs can be compared directly [15] [16] [17] , as can experiments performed in virus particles or in crystals, which is not true for slower reacting reagents. Finally, because 1M7 is well-validated for SHAPE-directed secondary structure modeling, this reagent also makes it possible to model novel RNA structures in vivo 16, 17, 31 .
Random priming. Conventionally, random hexamers have been used to prime cDNA synthesis; however, these primers lead to wildly unbalanced sequencing coverage of RNAs that is exacerbated in RNAs with a low fraction or uneven distribution of G and C nucleotides. To resolve this challenge, we use randomized 9-mer primers (Fig. 6) 28 . These primers perform better than shorter random primers for all RNAs that we have evaluated. For sequences in which GC content is low or unevenly distributed, we use 'LNA+' primers 28 . These primers omit cytosine to disfavor guanosine binding, they contain 2,6-diaminopurine to favor binding to uracil and they include locked nucleic acid monomers (Fig. 6) to increase affinity. We recommend using LNA+ primers when the median GC count of 15-nt sliding windows along the length of the RNA sequence of interest is <7; otherwise, we recommend the use of randomized 9-mer primers.
SuperFold options and advanced features. Several options can be used to modify SuperFold operation (Box 2). A full explanation of command-line options is available in the README file included with the software. For example, the number of processors available to SuperFold should be set using the flag '--np'. This number is typically four or more on a desktop workstation.
Known pseudoknots can be included in the SuperFold structure prediction using a user-generated file, PKREGION, a tab-separated file with one nucleotide pair entered on each line. Nucleotide pairs included in this file will be forced to be single-stranded during partition function and fold calculations. These pairs are added manually during the consensus structure generation step (Fig. 3) . Similarly, nucleotides that are known to be single-stranded (from complementary biological experiments) can be forced to be single-stranded using a SSREGION file. Spacing between partition function windows. Default: 100 nt.
Box 2 | Command-line flags to modify how SuperFold runs individual stages
Length of the Fold window size. Default: 3,000 nt.
Spacing between Fold windows. Default: 300 nt.
--drawSS
Include secondary structure diagrams for expanded regions of low SHAPE and Shannon entropy using the Pseudoviewer 59 web service.
The use of a .map file alone means that RNA secondary structure modeling will be performed using the ∆G SHAPE pseudo-freeenergy change term for reactivities based on the well-validated 1M7 SHAPE reagent. This approach generally yields high-quality secondary structure models 19, 20 . It is also possible (and recommended) to incorporate data from 'differential', or three-reagent, SHAPE experiments 21 by incorporating the results of probing with 1M6 and NMIA, using a .mapd file. 
Step Tables 3 and 4 for appropriate sequences. The first PCR step is performed using Step1 Fwd and Step1 Rev primers, where [RNA-specific] is a 15-20-nt sequence specific to, and in the same sense as, the RNA of interest and [RT primer] is an appropriate antisense sequence (this is typically the same sequence as the reverse transcription primer; it may be an RNA-specific sequence if random primers were used). A randomized 5-nt sequence immediately 5′ to the RNA-specific sequence is required for optimal cluster identification on Illumina instruments. The second PCR step is performed using the 'universal' primers Uni Fwd and Uni Rev , where [Barcode] is a 6-nt sequence identifier to enable sample multiplexing. These primers do not require complementarity to the RNA of interest; a single set can be purchased and used with any RNA. Note that the reverse complement of the [Barcode] sequence will be read by Illumina sequencers and used for demultiplexing. Thus, it is important to use the reverse complement of the [Barcode] sequence when configuring the sequencing run. 
2|
Incubate the RNA at 95 °C for 2 min, and then place it immediately on ice for at least 2 min.
3| Add 6 µl of 3.3× folding buffer, and mix it thoroughly by pipetting.
4|
Allow the RNA to fold at the desired temperature (typically 37 °C) for 20 min.
rna modification • tIMInG 30 min 5| Aliquot 1 µl of 100 mM 1M7 (for the (+) 1M7 reaction) and 1 µl of neat DMSO (for the (−) reaction) into separate 0.65-ml reaction tubes.
6| Add 9 µl of folded RNA from Step 4 to the (+) and (−) reaction tubes, mix vigorously by pipetting and incubate the tubes at a desired temperature for five 1M7 hydrolysis half-lives (~75 s at 37 °C).  crItIcal step Add RNA solution to the smaller reagent volume to ensure thorough, rapid mixing. It is important to thoroughly mix the reaction components immediately after the addition of RNA. Add RNA to one reaction, mix it and begin incubation before moving on to the next reaction.
7|
After the reaction has proceeded to completion, place the reaction tubes on ice while performing the denaturing control reaction (Steps 8-11).
8| Add 5 pmol of fresh RNA in 3 µl of sterile water, 5 µl of 100% formamide and 1 µl of 10× DC buffer to a 0.65-ml reaction tube. Mix it well.
9|
Incubate the mixture at 95 °C for 1 min to denature the RNA.
10|
Add 1 µl of 100 mM 1M7 into a clean 0.65-ml reaction tube for the DC reaction.  crItIcal step Do not preincubate the SHAPE reagent at 95 °C. At elevated temperatures, the competing hydrolysis reaction proceeds quickly; moisture in the tube can reduce the effective concentration of SHAPE reagent.
11| Add 9 µl of denatured RNA to the DC reaction tube, mix it well and incubate it at 95 °C for 1 min. Place the DC reaction tube on ice while preparing the G-25 spin columns.
12|
Bring the total volume of each sample to 50 µl with RNase-free water, and purify the RNA from the (+), (− 
18|
Heat the reactions to 70 °C for 15 min to inactivate SuperScript II reverse transcriptase. Place them on ice or hold them at 4 °C.  crItIcal step If cDNA is to be converted to dsDNA via second-strand synthesis (randomer workflow), keep the reverse transcription product cold (but not frozen). Second-strand synthesis requires the annealed RNA-DNA hybrids produced during reverse transcription to be intact.  pause poInt The reverse transcriptase product can be kept at 4 °C overnight. (ii) Place the PCR plate in a preheated thermocycler and cycle through the following program:  crItIcal step PCR reactions should produce a single band of the expected size. Reaction conditions should be optimized to achieve pure reaction products. Gel purification is recommended when off-target products cannot be avoided. Quality control and sample dilution • tIMInG 2 h 21| Measure the library concentration using a Qubit fluorometer or other high-sensitivity assay. ? troublesHootInG 22| Evaluate the library size distribution using an Agilent 2100 Bioanalyzer according to the manufacturer's instructions. Libraries generated with the small RNA workflow should appear as a single, well-defined peak. Libraries generated with the amplicon workflow should exhibit a lower size limit of ~250 bp and an upper length corresponding to the input amplicon. Libraries generated with the randomer workflow should exhibit a length distribution between ~250 and 1,500 bp (Fig. 5) .
? troublesHootInG 23| Calculate library molarity using either option A (small RNA workflow) or option B (amplicon workflow or randomer workflow). Current Illumina instruments require library concentrations of at least 2 nM. 
26|
Check that no spaces are present in the path to this directory (the perl script that calls Bowtie2 fails if spaces are present).
27|
Copy or move uncompressed FASTQ sequencing read files (.fastq) from
Step 24 into the RUN folder. Example data are available at the Sequence Read Archive, SRP052065.
28|
Create a FASTA-formatted sequence file (.fa) for each target sequence of interest. If you are analyzing the example data, copy the sequence files from the ShapeMapper folder into the RUN folder. Note the following: the first line of each FASTA file is the '>' character followed by a sequence name; the remaining lines are the DNA sequence; the filename must exactly match the sequence name after the '>' character; there should be no space between the '>' character and the sequence name; and you must use 'T', not 'U', in sequences. Use all capital letters for sequence.
29| Copy the EXAMPLE.cfg file provided with ShapeMapper into the RUN folder and give the file a new name.
30| Edit the configuration file using a text editor (Steps 30-35).
See box 1 for an example configuration file. If the FASTQ files produced by the sequencing platform are likely to contain poor-quality base-calls at the beginning of the reads (for example, those sometimes produced by the HiSeq or NextSeq instruments), set the 'windowSize' parameter to '3' . This will allow the 'trimPhred' stage to use a windowed average base-call quality score instead of a single base-call cutoff.
31|
If paired-end sequencing was performed, set the 'alignPaired' parameter to 'True' .
32|
If random priming was performed and cDNA libraries were prepared without using Nextera kits, set the 'randomlyPrimed' parameter to 'on' and the 'primerLength' parameter to the length of the primers. ShapeMapper will then ignore mutations occurring within 'primerLength' +1 nt on the 3′ end of reads (as differences between random primers and native sequence do not correspond to sites of SHAPE modification). If tagmentation (Nextera kit) was used, the 'randomlyPrimed' parameter should be set to 'off' even if random primers were in fact used in reverse transcription. The Nextera protocol involves enzymatic cleavage of DNA ends, so computational removal of primer regions is not necessary.
33|
If cDNA libraries were prepared using a Nextera kit, we recommend setting the 'maxInsertSize' to 800 (this corresponds to the Bowtie2 '--maxins' parameter). Otherwise, the default value of 500 is appropriate. 34| Add sample names followed by alignment targets to the '[alignments]' section. If FASTQ filenames do not follow Illumina naming convention, specify full filenames using the alternative syntax shown.
35| Specify the samples that should be combined into reactivity profiles in the '[profiles]' section. Profile names are user-specified.
36| Execute ShapeMapper (Steps 36-38). Open a command-line terminal.
37| Browse to the RUN directory. This command may vary depending on the specific cluster configuration. Expected output: information about run progress or failure will be written to 'log.txt'; reactivity profiles will be written to the 'reactivity_profiles' subfolder within the output folder (table 2). Images of each profile, showing SHAPE reactivity versus nucleotide position, are also written to this folder (Fig. 7) . Images of the read depth versus nucleotide position for each RNA will be produced (Fig. 8) . Histograms of mutation rates, read depths, SHAPE reactivities and s.e.m. (useful for experiment troubleshooting) will be produced (Fig. 9) . Intermediate files for each analysis stage will be written to the disk (table 2) .  crItIcal step Analysis of the example ShapeMapper data requires 20 min on a 12-core, 2.93 GHz Dell C6100 server. This is a typical run-time for target RNAs that are <100,000 nt and for the amount of data generated from a single MiSeq sequencing instrument run. Larger data sets or longer target sequences increase the run-time. ? troublesHootInG superFold analysis • tIMInG 1 h or more 39| To model the RNA structure, use the .map or .mapd file generated by ShapeMapper (see box 3 for a description of file formats) in SuperFold by typing the following command. Note that SuperFold is typically run with default settings for folding window sizes.
SuperFold.py 16SrRNA.map Expected outcome: three folders are created, namely 'fold_', 'partition_' and 'result_'; each underscore is followed by the name of the input .map file and a short signature created from a MD5 hash of the flags. The parameters used to fold the RNA
Box 3 | SuperFold file formats
Examples of file formats are included with the SuperFold executable. Descriptions of the formats are provided here.
Map file. A ' .map' file is required to run SuperFold. This file is created automatically in the Results folder of ShapeMapper. The .map file is a tab-separated text file with four columns: nucleotide number, SHAPE reactivity, standard error and sequence. SHAPE reactivity and standard error values set to −999 are interpreted as no data.
MapD file. For three-reagent 'differential' SHAPE folding, a ' .mapd' file is required. In a differential experiment, the Python program differenceByWindowMap.py generates a differential SHAPE-MaP file (.mapd) from two .map files that report reactivities using the 1M6 and NMIA reagents. Use of the .mapd file in SuperFold results in incorporation of differential SHAPE reactivity into the SHAPE free-energy term 21 . The .mapd file is a tab-separated text file with five columns: nucleotide number, differential SHAPE reactivity, standard error, sequence and Z-factor. SHAPE reactivity and standard error values set to −999 are ignored. and the status of the run are written to the log file in the results directory. (Fig. 5) that are interpreted using automated postsequencing processing using ShapeMapper to yield final SHAPE reactivities (Figs. 7 and 10) . These SHAPE reactivities provide a starting point for modeling RNA secondary structure using SuperFold, which is optimized for long sequences (2,000 nt and much longer), but also works well for modeling shorter RNAs (Figs. 11 and 12) . Distinct experimental workflows are optimized for probing small, low-abundance or complex mixtures of RNA. Here we briefly present representative results obtained with two of the three workflows, the small RNA and randomer workflows. A SHAPE profile for the aptamer domain of the TPP riboswitch was readily obtained using the small RNA workflow. Using these data, secondary structure modeling for this riboswitch RNA improved from a base pair prediction accuracy of 73%, obtained using a nearest-neighbor thermodynamic algorithm alone, to 96%, using SHAPE-directed modeling 28 . Observed reactivities correspond closely to those expected based on the local nucleotide flexibilities for the ligand-bound RNA (Fig. 10a,c) . Reactive nucleotides fall in conformationally flexible single-stranded regions, especially the L3 loop and the J2-4 and J3-2 strands. Overall, relatively few nucleotides are reactive by SHAPE, consistent with the highly constrained conformation of this RNA. SHAPE-MaP also reveals fine differences corresponding to changes induced upon binding by the TPP ligand (Fig. 10b,d) . Ligand interactions induce a large structural organization in the L5 loop and in the J3-2 elements in the ligand-binding pocket.
Large RNAs such as the bacterial small and large ribosomal subunit RNAs (16S and 23S, respectively) are readily examined by applying the Randomer Workflow to total E. coli RNA (Fig. 13) . By using random primers, both RNAs can be studied simultaneously with fully automated analysis involving ~3 d of hands-on experimental effort. The major postprocessing requirement is that the per-nucleotide hit level be sufficiently high to permit full recovery of the underlying SHAPE data. In general, the hit level should be 5 or greater, corresponding to a read depth of 1-2,000 (ref. 28) .
The 23S rRNA subunit alone represents ~2,900 nt of SHAPE reactivity information after computational data processing (Fig. 13a) . Comparing the SHAPE reactivities for domain IV of the 23S rRNA with the accepted sequence covariationderived structural model (Fig. 13b,c) shows good agreement. Regions involved in canonical base pairs have low SHAPE reactivity, indicating that they are structurally constrained. Conversely, single-stranded loop and bulge regions have high SHAPE reactivity, indicating structural flexibility. Because of the inherent scalability of the MaP approach, these data-spanning several thousand nucleotides-are as accurate at single-nucleotide resolution as are data from a short RNA, such as the TPP riboswitch. After the ShapeMapper analysis is complete, the rendered SHAPE reactivity profiles provide a clear view of the general success of an experiment (.pdf files in the 'reactivity_profiles' folder). A successful experiment should have only a small number of negative gray bars (indicating no-data points) and small error bars (Fig. 7a) .
The majority of SHAPE-MaP experiments are strikingly successful. The data obtained are reproducible, robust, correlate well with previous, well-validated approaches for SHAPE readout 28 , enable consistent high-accuracy RNA structure modeling 21 and recover detailed information about structural ensembles 48 . In our laboratory, it is routine for full biological replicates, Regions with both low SHAPE reactivity (corresponding to high levels of RNA structure) and low Shannon entropy (reflecting a well-determined structure) are emphasized with blue shading. Note that the TPP riboswitch and ribosomal RNAs almost entirely comprise low-SHAPE and low-entropy regions, whereas the HIV-1 RNA genome alternates between regions of well-determined structure and those without. TPP riboswitch Ribosome 5′ domain performed months apart by different individuals, to yield identical experimental results, within narrow error limits 28 . However, when problems do occur, the SHAPE reactivity profiles, along with other ShapeMapper outputs, provide important clues for troubleshooting and identifying potential causes. The most common cause of a failed SHAPE-MaP experiment is insufficient sequencing depth. SHAPE-MaP cDNA libraries sequenced to low depths do not produce high-confidence SHAPE reactivity profiles (as evidenced by large error bars, Fig. 7b ) and, consequently, they do not enable accurate structural modeling (see Fig. 3 in the original SHAPE-MaP publication 28 ). We recommend sequencing to read depths above ~2,000 for each experimental condition to obtain high-confidence SHAPE reactivities and accurate structure models.
Read depths can be assessed directly by examining the profiles produced by ShapeMapper. For experiments using the small RNA workflow, a relatively flat depth profile is desirable and typically achieved (Fig. 8a) . A depth profile with bumps or steps indicates possible offtarget or nonspecific primer binding. Enzymatic fragmentation and tagging (Nextera) results in lower read depth near the transcript ends because of the inability of the enzymes to cleave near the ends of a double-stranded DNA. In addition, read-depth profiles for libraries prepared in this way often exhibit a spikiness that probably results from sequence preferences during the fragmentation step. The amplicon workflow results in relatively flat profiles in the middle of a transcript (Fig. 8b) , whereas the randomer workflow typically produces less even depth profiles (Fig. 8c) because of the differential efficiency of primer binding. Regions of low read depth, even if embedded in areas of high median read depth, do not produce reliable reactivity profiles by SHAPE or any other structure probing approach. Specially designed primers can improve or smooth the distribution of read depths for RNAs with AU-rich regions (Fig. 6) 28 .
ShapeMapper produces multiple histograms that are useful for distinguishing successful from problematic experiments. For example, a successful experiment will show that the vast majority of nucleotides have read depths above 2,000 (Fig. 9a,  center) , whereas an unsuccessful experiment (Fig. 9b, center) may have low overall sequencing depth. A successful SHAPE-MaP experiment also requires sufficient levels of SHAPE modification above background, efficient reverse transcription and the absence of DNA contamination. In a successful experiment (Fig. 9a, right) , reactivities are mostly positive, and the standard errors are smaller than most of the reactivities. Successful experiments are characterized by mutation rates in the no-reagent sample between 0 and 0.2%, a strong shift toward higher mutation rates in the plus-reagent sample and a slight shift in the denaturing control sample (Fig. 9a, left ). An example of low mutation above background, probably due to low levels of SHAPE modification, is illustrated in Figure 9d , left. A noisy SHAPE reactivity profile (for example, Fig. 7b ) is also indicative of a failed experiment.
The SuperFold analysis pipeline provides a solution to another challenge in analyzing large RNAs: automated visualization of secondary structures (Fig. 12) . Two separate visualization approaches are implemented in SuperFold: (i) circle plots, which provide an impartial model-free view of secondary structure and enable rapid visualization of pseudoknots, and (ii) traditional secondary structure diagrams available through the Pseudoviewer 59 web service. Connectivity (.ct) and XRNA (http://rna.ucsc.edu/rnacenter/xrna/) files are provided that can be used as input to other structure visualization programs.
A melded Shannon entropy and SHAPE analysis (Fig. 11) is particularly useful for identifying regions of RNA that have well-determined folds and for identifying parts of an RNA that merit detailed follow-up analysis for function. Three different examples of expected output are shown: the E. coli thiamine pyrophosphate aptamer domain, the entire 16S rRNA and the entire HIV-1 RNA genome (Fig. 11) . Regions that contain both low Shannon entropy and low SHAPE reactivity appear to be highly likely to harbor functional elements 28, 31 . After expanding low Shannon entropy/SHAPE regions to include overlapping minimum free-energy helices, almost the entirety of the TPP riboswitch and ribosomal RNAs comprise low-Shannon-entropy or low-entropy regions (Fig. 11, purple shading) , consistent with their known roles as RNAs whose function requires a specific well-defined fold. In contrast, the HIV-1 RNA genome has regions with low Shannon entropy and low SHAPE reactivity and also many regions that are predicted not to form well-defined structured states (Fig. 11c) . Pairing probability arcs illustrate a relatively simple set of probable base pairs (derived from the partition function) for the TPP riboswitch and the 16S rRNA (Fig. 11a,b, see green arcs) . In contrast, the HIV-1 RNA genome features both well-determined structural motifs and regions where the probability of formation of a single stable structure is low (Fig. 11c) .
In sum, SHAPE-MaP and the ShapeMapper and SuperFold pipelines yield quantitative nucleotide-resolution RNA structural information, enable accurate secondary structure modeling, identify well-determined regions within large RNAs, facilitate discovery of novel functional RNA motifs, make possible deconvolution of sequence polymorphisms in a single experiment, detect diverse effects of ligand and protein binding, readily allow analysis of low-abundance RNAs and scale gracefully from short RNAs to transcriptome-wide analyses, including in cells. We anticipate that SHAPE-MaP will contribute to a deeper understanding of the relationships between RNA structure and function. 
